SCHEMBL31728484

SCHEMBL31728484

COc1ccc2c(N)ncnc2c1-c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.46
▸ MAP4K4 O95819 2/20 0.45
▸ LIMK1 P53667 1/20 0.45
▸ ADK P55263 1/20 0.40
▸ TSHR P16473 4/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ CYP2D6 P10635 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ TP53 P04637 2/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ FGB P02675 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728253 0.88 PDE5A (0.42) PDE5AMAP4K4LIMK1ADKHSP90AA1
SCHEMBL31729201 0.76 EGFR (0.40) MAPK1MAPTADORA2ASRCL3MBTL1
SCHEMBL31728942 0.73 MCL1 (0.33) PDE5AMAP4K4LIMK1CYP3A4CYP2C19
SCHEMBL26501336 0.72 PDE5A (0.56) PDE5AMAP4K4LIMK1CYP3A4PLAU
SCHEMBL31728075 0.72 EGFR (0.42) PDE5AMAP4K4LIMK1ADKCYP3A4
SCHEMBL17142275 0.71 PDE5A (0.51) PDE5AMAP4K4LIMK1ADKCLK4
Hydrochloric Acid SCHEMBL28311213 0.70 PDE5A (0.54) PDE5AMAP4K4LIMK1CYP3A4PLAU
SCHEMBL31727897 0.70 LIMK1 (0.36) MAP4K4LIMK1ADKALDH1A1MAPT
SCHEMBL31728730 0.70 PDE5A (0.36) PDE5AMAP4K4LIMK1ADKALDH1A1
SCHEMBL31728545 0.69 DGAT1 (0.39) MAP4K4LIMK1MAPK1CYP2D6CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback